1. The daily urine excretion has been studied of prostaglandins (PG) E 2 and F 2a , as measured by radioimmunoassay, in eight children and seven adults with Bartter's syndrome.
Introduction
Bartter's syndrome, which was first described in 1962, is characterized by hypokalaemic alkalosis, renal potassium wasting, normal blood pressure, increased plasma renin activity with marked resistance to the pressor effects of angiotensin, hyperaldosteronism and juxtaglomerular cell hyperplasia. Several hypotheses have been put forward to explain the pathogenesis of the syn drome; these include primary arteriolar hyporesponsiveness to angiotensin II (Bartter, Pronove, Gill & McCardle, 1962) , impaired sodium «ab sorption at proximal nephron sites (Cannon, Leeming, Sommers, Winters & Laragh, 1968) (Cannon et al, 1968; Beilin, Schiffman, Crane & Nelson, 1967; Bracket, Koppel, Randall & Nixon, 1968) , acquired renal injury including glomerulitis (Cannon et al, 1968) and alterations in the permeability characteristics of the cell membrane to sodium (Gall, Vaitukaitis, Haddow & Klein, 1971) . Recently Verberckmoes, Clement, Michielsen & Van Damme (1976) , having successfully treated one patient with indomethacin, suggested that excessive prostaglandin (PG) production could be a proximal cause of this syndrome. Sub sequently Fichman, Telfer, Zia, Speckart, Golub & Rude (1976) reported an increased level of immunoreactive PGA 2 in the peripheral venous blood of an 18-year-old patient and Gill, Frölich, Bowden, Taylor, Keiser, Seyberth & Bartter (1976) observed enhanced urinary excretion of prosta glandins in four patients. These authors concluded that Bartter's syndrome is characterized by high concentrations of urinary prostaglandins and pro posed that the hyper-reninaemia was dependent on prostaglandin synthesis. To test this proposal we have analysed plasma and urine prostaglandins, using a sensitive and specific radioimmunoassay in eight children and seven adults with this disease.
Materials and methods
Urinary excretion of PGE 2 and PGF 2(r was measured in 15 patients with Bartter's syndrome and plasma concentrations of the same compounds were determined in 10 patients. All patients showed hypokalaemia, increased plasma renin activity, hyperaldosteronism and unresponsiveness to angio tensin perfusion, which are criteria for Bartter's syndrome. Ten of the 15 patients, five of the children and five adults, showed hyperplasia of the 115 juxtaglomerular apparatus. Of the remaining five, one was normal and the others were not tested. In all 15 arterial blood pressure and renal function were normal. All the children had greater or lesser growth retardation and those 14 and 15 years old had no clinical and morphological signs of puberty. In the seven adult patients there was no history of diarrhoea or vomiting. AU patients were on diets which contained at least 100 mmol of sodium/day. PG species were analysed when all the normal subjects and almost all the patients (five children and five adults) were ambulatory.
The same methods for extraction, chromatography and radioimmunoassay described for plasma (Dray, Charbonnel & Maclouf, 1975 Maclouf, Andrieu & Dray, 1975) were applied to urine, various and appropriate dilutions of samples in duplicate being used. Since PGF 2 a antiserum cross-reacts completely with P G F 1 O , we report immunoreactive PGF a ( 1 + 2 ) as PGF 2 " equiva lents. Values are given as mean ± 1 SEM. Significance of differences was assessed by un paired i-tests.
Results
In normal subjects (10-50 years old) the mean PGE 2 was 0-012 ± 0-006 pmol/ml (« = 12) and mean PGF 2 o was 0-027 ± 0-014 pmol/ml (n = 61). No difference in values was found between children and adults. In the 10 cases of Bartter's syndrome studied, normal values were found for PGE 2 (0-014 ± 0-002 pmol/ml) and for PGF 2o (0-03 ± 0-02 pmol/ml). There was no significant difference between values for children {n = 6) and adults (« = 4).
In normal subjects, the data on urinary ex cretion, expressed as nmol of PG/day or nmol/mg of creatinine or corrected body area, differed between children before puberty and adults more significantly for PGE 2 (P < 0-001) than for PGF 2 a (P < 0-05). Their results are therefore presented separately (Table 1) .
Urinary PGE 2 was high in eight children with Bartter's syndrome, including the two who had been receiving indomethacin therapy (75 mg/day) for at least 2 weeks. The mean value from the six patients receiving no therapy (0-99 ± 0-28 nmol/24h) was significantly greater (P < 0-001) than from prepubertal normal children of the same age range (0-24 + 0-07 nmol/24h; n = 17). Urinary PGF 2 a was also increased in these patients. The mean value of 4-51 + 2-06 nmol/24 h was three times that of normal children (1-52 ± 0-36 nmol/24 h; n = 17) (P < 0-01). In these six patients, the P G E 2 / P G F 2 Q ratio remained less than 1.
In contrast to the children the values for PGE 2 (1-06 ± 0-22 nmol/24 h) and PGF 2n (2-86 ± 1· 15 nmol/24 h) in the seven adult patients (20-47 years old) were not significantly different from those of 12 healthy adults (20-54 years old).
Discussion
Plasma concentrations of PGE 2 and PGF 2o in children and adults with Bartter's syndrome were not different from those in age-matched normal subjects, which is not surprising as these com pounds are rapidly cleared from the blood by several organs, including the lung. Thus it is possible that the increased production by the kidney may increase PG concentrations in renal venous blood and urine, but not in peripheral blood. In contrast to plasma, the urinary excretion differed, depending on whether the patient had achieved puberty. Before puberty, patients with Bartter's syndrome had markedly elevated urinary excretion rates of _PGE 2 and PGF 2o , in comparison with age-matched normal subjects. In contrast, the urinary output of PGE 2 and PGF 2a in postpubertal patients with Bartter's syndrome were not different from values obtained in age-matched normal individuals. Values of urinary PGE 2 and PGF 2 a excretion rates in normal subjects, reported by Gill et al. (1976) , are comparable with our results in normal females. Variations in age, diet and physical activity may account for the small differences. Such factors, however, cannot explain the difference between pre-and post-pubertal normal values in our study. It is possible that alteration in endocrine factors associated with the onset of puberty accounts, at least in part, for the difference in prostaglandin excretion rate which exists between pre-and post-pubertal normal subjects with and without Bartter's syndrome. However, we did not find the reason (s) for the lack of elevated urinary prostaglandin output in adult patients with Bartter's syndrome. Lack of elevated output of prostaglandins in adult patients may denote the existence of two subgroups of Bartter's syndrome patients, i.e. pre-and post-pubertal, differing in terms of the relative contribution of altered prostaglandin metabolism to the pathogenesis of the disorder. If this were the case, it would be logical to expect a greater effectiveness of indomethacin in prepubertal patients. However, the absence of elevated excretion of prostaglandins does not exclude either an increase of the renal PG release or increased production during phospholipid and/or arachidonic acid metabolism; recently, Weber, Larsson, Anggard, Hamberg, Corey, Nicolaou & Samuelsson (1976) have shown that PG endoperoxides stimulate renin secretion in the rabbit renal cortex. Conversely, a normal rate of excretion of prostaglandins in postpubertal in dividuals should not exclude the diagnosis of Bartter's syndrome.
